"The European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approval of dalbavancin 500 mg (Xydalba, Durata Therapeutics) for acute bacterial skin and skin structure infections (ABSSSI) in ad"...
DOSAGE AND ADMINISTRATION
See application instructions.
Treatment of tinea versicolor: Apply to affected areas and lather with a small amount of water. Allow product to remain on skin for 10 minutes, then rinse thoroughly. Repeat procedure once a day for 7 days.
Treatment of seborrheic dermatitis and dandruff: Usually two applications each week for two weeks will afford control. After this, may be used at less frequent intervals weekly, every two weeks, or every 3 or 4 weeks in some cases. Should not be applied more frequently than required to maintain control.
APPLICATION INSTRUCTIONS: Keep tightly capped.
Shake well before using. Product may damage jewelry; remove jewelry before use.
For treatment of tinea versicolor:
- Apply to affected areas and lather with a small amount of water.
- Allow to remain on skin for 10 minutes.
- Rinse body thoroughly.
- Repeat this procedure once a day for 7 days.
For treatment of dandruff and seborrheic dermatitis of the scalp:
- Massage about 1 or 2 teaspoonfuls of shampoo into wet scalp.
- Allow to remain on scalp for 2 to 3 minutes.
- Rinse scalp thoroughly.
- Repeat application and rinse thoroughly.
- After treatment, wash hands well.
- Repeat treatments as directed by physician.
WARNINGS AND PRECAUTIONS:
For External Use Only. Do not use on broken skin or inflamed areas. If allergic reactions occur, discontinue use. Avoid getting shampoo in eyes or in contact with genital area and skin folds as it may cause irritation and burning. These areas should be thoroughly rinsed after application. Keep this and all medicines out of reach of children.
Store below 86°F (30°C).
4-fl-oz bottles (NDC 0074-2660-04).
Last reviewed on RxList: 12/8/2004
This monograph has been modified to include the generic and brand name in many instances.
Additional Selsun Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.